Prot #M16-802: A Multicenter, Open-Label Phase 1b Study to Assess Safety and Efficacy of Venetoclax in Combination with Gilteritinib in Subjects with Relapsed/Refractory Acute Myeloid Leukemia.

Project: Research project

Project Details

StatusFinished
Effective start/end date2/27/19 → 2/27/23

Funding

  • AbbVie Inc. ((OE) Prot #M16-802)